<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>To investigate the association between fasting <z:chebi fb="105" ids="17234">glucose</z:chebi> and C-reactive protein (CRP), we examined 1715 Japanese individuals (723 men and 992 women) aged 40-69 years who did not have medication for <z:hpo ids='HP_0000822'>hypertension</z:hpo>, <z:mp ids='MP_0002055'>diabetes</z:mp>, or <z:e sem="disease" ids="C0242339" disease_type="Disease or Syndrome" abbrv="">dyslipidemia</z:e>, a history of <z:e sem="disease" ids="C0007222" disease_type="Disease or Syndrome" abbrv="CVD">cardiovascular disease</z:e> or CRP levels&gt;10mg/l </plain></SENT>
<SENT sid="1" pm="."><plain>There was a statistically significant unadjusted correlation between CRP and each component of the <z:e sem="disease" ids="C0948265" disease_type="Disease or Syndrome" abbrv="">metabolic syndrome</z:e>, including fasting <z:chebi fb="105" ids="17234">glucose</z:chebi>, fasting insulin, body mass index, systolic blood pressure, diastolic blood pressure, <z:chebi fb="1" ids="47775">high-density lipoprotein cholesterol</z:chebi> (negative), and <z:chebi fb="4" ids="17855">triglycerides</z:chebi> in both men and women </plain></SENT>
<SENT sid="2" pm="."><plain>With adjustment for age, cigarette smoking, alcohol intake, and other components of the <z:e sem="disease" ids="C0948265" disease_type="Disease or Syndrome" abbrv="">metabolic syndrome</z:e>, the CRP increments (as back-transformed) compared with the lowest tertile of <z:mpath ids='MPATH_458'>normal</z:mpath> fasting <z:chebi fb="105" ids="17234">glucose</z:chebi> were 0.99, 1.05, 1.21, and 1.34mg/l (P for trend=0.008) with the second lowest and highest tertiles of <z:mpath ids='MPATH_458'>normal</z:mpath> fasting <z:chebi fb="105" ids="17234">glucose</z:chebi>, impaired fasting <z:chebi fb="105" ids="17234">glucose</z:chebi>, and type-2 <z:mp ids='MP_0002055'>diabetes</z:mp>, respectively in men </plain></SENT>
<SENT sid="3" pm="."><plain>The respective adjusted CRP increments were 1.12, 1.23, 1.33, and 1.93mg/l (P for trend&lt;0.001) in women </plain></SENT>
<SENT sid="4" pm="."><plain>In the stratified analyses of CRP levels by sex, <z:hpo ids='HP_0001513'>obesity</z:hpo> status, and fasting <z:chebi fb="105" ids="17234">glucose</z:chebi> category or the number of components of the <z:e sem="disease" ids="C0948265" disease_type="Disease or Syndrome" abbrv="">metabolic syndrome</z:e>, an increase in CRP levels was greater in women than men with <z:hpo ids='HP_0001513'>obesity</z:hpo> and higher fasting <z:chebi fb="105" ids="17234">glucose</z:chebi> category (gender interaction: P&lt;0.001) or an increased number of components of the <z:e sem="disease" ids="C0948265" disease_type="Disease or Syndrome" abbrv="">metabolic syndrome</z:e> (gender interaction: P=0.003) </plain></SENT>
<SENT sid="5" pm="."><plain>These results indicate that CRP levels increase continuously across the spectrum of fasting <z:chebi fb="105" ids="17234">glucose</z:chebi> in both sexes </plain></SENT>
<SENT sid="6" pm="."><plain>This association is more pronounced in women </plain></SENT>
</text></document>